Equities

Create SD Holdings Co Ltd

3148:TYO

Create SD Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)3,440.00
  • Today's Change10.00 / 0.29%
  • Shares traded199.60k
  • 1 Year change+1.78%
  • Beta0.5514
Data delayed at least 20 minutes, as of May 10 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CREATE SD HOLDINGS CO.,LTD. is a Japan-based holding company primarily engaged in the drug store business. Through its subsidiaries, the Company mainly is engaged in the retail sale of pharmaceuticals and cosmetics. The drug store business sells pharmaceuticals, cosmetics, food products, miscellaneous goods and others. The pay nursing home business and day service business operates pay nursing homes and day service centers.

  • Revenue in JPY (TTM)411.72bn
  • Net income in JPY13.90bn
  • Incorporated1998
  • Employees4.73k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yakuodo Holdings Co Ltd142.24bn3.83bn56.16bn969.0014.571.678.450.3948195.20195.207,259.051,700.132.054.8587.88--5.525.548.438.6721.5722.402.692.720.3559168.030.289814.3610.449.1518.025.37-15.284.36
Cawachi Ltd285.96bn4.71bn69.50bn2.77k13.410.56737.710.243210.78210.7812,788.754,983.151.466.5033.52--2.412.573.543.8223.0122.571.651.760.8316580.380.130724.451.451.4712.8318.5114.1912.20
Qol Holdings Co Ltd178.46bn5.27bn71.97bn5.75k13.051.346.890.4033141.81141.814,801.101,384.571.6121.8710.7131,058,650.004.764.707.907.5413.0713.202.952.840.9217--0.362524.302.313.163.042.5520.482.90
Genky DrugStores Co Ltd181.44bn5.91bn89.85bn1.75k14.931.977.960.4952388.53388.5311,933.872,948.951.746.6951.56103,503,100.005.684.618.637.4020.3121.183.262.810.34992.800.41369.769.3212.257.778.8513.4214.87
AIN Holdings Inc391.20bn11.34bn212.29bn10.65k18.571.589.710.5427322.68322.6811,135.343,791.571.6513.1730.9636,728,570.004.794.108.126.6614.6315.712.902.680.7907--0.0423.9713.445.9830.20-2.6626.793.71
Create SD Holdings Co Ltd411.72bn13.90bn229.86bn4.73k16.081.7512.280.5583213.90213.906,326.441,970.862.148.1032.1887,025,370.007.227.6210.8512.1126.2827.443.383.570.8374--0.0023.018.627.272.626.2619.378.87
Kusuri No Aoki Holdings Co Ltd423.36bn8.64bn274.81bn4.46k31.822.4412.890.649191.2991.294,475.411,191.111.567.0042.3894,923,100.003.186.144.609.4927.3528.262.043.660.770465.450.42476.3715.3911.3525.286.927.9012.63
Sugi Holdings Co Ltd744.48bn21.98bn443.25bn7.73k19.211.8112.280.5954121.46121.464,114.161,289.592.016.5218.18--5.926.118.999.3030.7430.382.953.210.8443--0.003623.9411.518.7915.644.1412.582.71
Welcia Holdings Co Ltd1.22tn26.45bn482.00bn14.87k17.982.009.470.396127.85127.855,879.061,150.652.246.3720.73--4.845.768.2710.2330.4030.812.162.510.550744.990.252923.816.389.33-2.148.712.5910.12
Tsuruha Holdings Inc1.01tn27.10bn493.94bn11.30k17.981.7110.410.4877554.77554.7720,729.875,827.221.894.8922.4189,640,290.005.566.038.7510.0130.4229.352.943.160.680338.960.143735.085.947.5818.090.368321.9812.23
Sundrug Co Ltd736.88bn28.12bn511.81bn6.37k17.842.0312.040.6946240.46240.466,301.252,109.592.026.3328.21115,661,800.007.708.2511.2512.0225.3524.813.823.850.9663--0.0035.786.434.127.760.694315.9510.76
Cosmos Pharmaceutical Corp936.71bn24.87bn546.21bn5.29k21.752.4112.390.5831627.89627.8923,646.835,659.542.329.862,065.50177,071,100.006.167.0210.9613.3719.6520.032.663.180.17841,267.960.045612.249.578.212.776.189.6317.32
MatsukiyoCocokara & Co1.02tn52.35bn985.18bn13.66k18.341.8616.910.9635125.28125.282,447.251,233.951.454.8517.46--7.456.809.758.8734.6333.455.154.571.29--0.0386--7.4912.1629.1115.9029.38--
Data as of May 10 2024. Currency figures normalised to Create SD Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

21.03%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 29 Dec 20234.54m6.79%
Orbis Investment Management Ltd.as of 26 Feb 20243.69m5.52%
Mawer Investment Management Ltd.as of 31 Dec 20231.75m2.62%
Nomura Asset Management Co., Ltd.as of 29 Mar 20241.36m2.03%
The Vanguard Group, Inc.as of 05 Apr 2024839.32k1.26%
Nikko Asset Management Co., Ltd.as of 05 Apr 2024489.80k0.73%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024446.20k0.67%
Dimensional Fund Advisors LPas of 04 Apr 2024360.07k0.54%
BlackRock Fund Advisorsas of 04 Apr 2024323.20k0.48%
Grandeur Peak Global Advisors LLCas of 31 Jan 2024259.70k0.39%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.